School of Medicine
Showing 161-180 of 537 Results
-
David Tehrani, MD, MS
Affiliate,
BioDr. Tehrani is a board-certified, fellowship-trained interventional cardiologist with Stanford Health Care Tri-Valley in the East Bay.
He is focused on building long-term relationships with his patients and their families, while sharing his evidence-based expertise in the noninvasive and minimally invasive management of cardiovascular disease. He takes pride in forming care plans based on mutual decision-making.
Dr. Tehrani’s research interests include cutting-edge technology and advancements in medical management of cardiovascular disease. His clinical research studies and funded clinical research trials have focused on cardiovascular biomarkers, coronary physiology, cardiac hemodynamics, cardio-oncology, and procedural closure devices. His research background has been instrumental in helping him provide individualized, evidence-based care plans for conditions ranging from advanced heart failure to complex coronary disease.
Dr. Tehrani has an extensive clinical research background, with over 40 peer-reviewed publications in top cardiology journals. He has done over 30 presentations at conferences, including the American Heart Association (AHA) and American College of Cardiology (ACC) national meetings.
Dr. Tehrani is a member the American College of Cardiology, the American College of Physicians, the American Heart Association, the Heart Failure Society of America, and the International Society of Heart and Lung Transplantation. -
Nicholas Telischak, MD, MS
Clinical Associate Professor, Radiology
Clinical Associate Professor (By courtesy), NeurosurgeryBioA native of the Bay Area, Dr. Nick Telischak is a dual fellowship-trained neurointerventional surgeon and neuroradiologist at Stanford Health Care. With board certifications in radiology and neuroradiology, he serves as a clinical associate professor in the Department of Radiology, and, by courtesy of the Department of Neurosurgery, at Stanford School of Medicine.
Dr. Telischak specializes in diagnosing and treating artery disorders in the brain and spine, including brain aneurysms, arteriovenous malformations (AVM), and dural arteriovenous fistula (dAVF), and stroke. Dr. Telischak also specializes in venous disorders in the brain including idiopathic intracranial hypertension (IIH). He also has a special interest in pulsatile tinnitus, a whooshing sound in the ears that occurs in rhythm with the heartbeat. Dr. Telischak also treats painful spinal (vertebral) fractures, spinal metastases (tumors resulting from cancer elsewhere in the body), and congenital vascular malformations (blood vessel abnormalities that are present at birth). He treats these conditions using minimally invasive, image-guided procedures and state-of-the-art technology.
Prior to joining Stanford Health Care, Dr. Telischak helped develop the Stroke Program at California Pacific Medical Center and Mills-Peninsula Medical Center, giving him a broad perspective on medical care systems within the Bay Area.
Dr. Telischak’s research focuses on:
• Identifying biomarkers to diagnose large vessel occlusion stroke (stroke in one of the large arteries in the brain)
• Noninvasive MRI techniques for diagnosing idiopathic intracranial hypertension (high pressure within the skull)
He is also the principal investigator for a study examining the efficacy of vertebroplasty and kyphoplasty for the treatment of painful vertebral compression fractures.
In addition, Dr. Telischak holds a master’s degree in bioengineering. He has worked with several companies pioneering new devices to treat brain aneurysms, vascular malformations, and strokes caused by blood clots, as well as new treatments for venous disorders in the brain caused by idiopathic intracranial hypertension.
Dr. Telischak has published more than 20 peer-reviewed articles and has been invited to present locally, nationally, and internationally at meetings for the Society of NeuroInterventional Surgery, American Society of Neuroradiology, and Jornada de Stroke in Asuncion, Paraguay, where he has served as visiting faculty. -
Melinda L. Telli, M.D.
Professor of Medicine (Oncology)
Current Research and Scholarly InterestsMy research focuses on the development of novel therapies for the treatment of triple-negative and hereditary cancer. Other areas of interest include prevention of cardiac damage associated with breast cancer treatment and cardiotoxicity of anti-cancer agents.
